Safety Procedures to Work with West Nile Virus in Biosafety Level 3 Facilities.
Methods Mol Biol
; 2585: 205-210, 2023.
Article
in En
| MEDLINE
| ID: mdl-36331776
ABSTRACT
West Nile virus (WNV) can cause severe and sometimes fatal disease, but we do not have treatments or therapeutics to manage these outcomes. Since its introduction to the USA in 1999, WNV has been handled in a biosafety level 3 laboratory to decrease risk to researchers, requiring strict safety protocols and important considerations with planning experiments. Recent changes in US guidelines suggest that WNV can be handled at a lower biosafety level due to its endemicity in the USA and generally minor symptoms, but some research still requires the use of the agent at biosafety level 3. This chapter will briefly discuss the considerations of biosafety when working with WNV.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
West Nile Fever
/
West Nile virus
Limits:
Humans
Language:
En
Journal:
Methods Mol Biol
Journal subject:
BIOLOGIA MOLECULAR
Year:
2023
Document type:
Article
Affiliation country:
United States